# Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer

> **NCT00911118** · PHASE1 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 120 (estimated)

## Conditions studied

- Prostate Cancer
- Adenocarcinoma

## Interventions

- **RADIATION:** Hypofractionated, image-guided, intensity-modulated external beam radiation

## Key facts

- **NCT ID:** NCT00911118
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05-26
- **Primary completion:** 2026-05-14
- **Final completion:** 2026-05-14
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00911118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00911118, "Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00911118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*